These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6604400)

  • 1. Positron emission tomography in dementia.
    Ferris SH; de Leon MJ; Wolf AP; George AE; Reisberg B; Christman DR; Yonekura Y; Fowler JS
    Adv Neurol; 1983; 38():123-9. PubMed ID: 6604400
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission computed tomography in the diagnosis of dementia.
    Benson DF; Kuhl DE; Phelps ME; Cummings JL; Tsai SY
    Trans Am Neurol Assoc; 1981; 106():68-71. PubMed ID: 6983757
    [No Abstract]   [Full Text] [Related]  

  • 3. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
    Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
    Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron imaging in dementing illnesses.
    Friedland RP
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S56-60. PubMed ID: 2535422
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of positron emission tomography to the diagnosis of dementia].
    Heiss WD; Herholz K; Pawlik G; Szelies B
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1362-7. PubMed ID: 3044727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebral and cardiovascular aging and brain energy metabolism. Studies with positron-emission tomography in man].
    Baron JC; Marchal G
    Presse Med; 1992 Jul; 21(26):1231-7. PubMed ID: 1409478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative measurement of glucose utilization in dog brain using positron emission tomogram and 18FDG.
    Hatazawa J; Yamaguchi T; Ito M; Kubota K; Fujiwara T; Yamaura H; Matsuzawa T; Kiyosawa M; Ido T
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):65-8. PubMed ID: 6611587
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization?
    Pardridge WM
    Ann Neurol; 1994 May; 35(5):511-2. PubMed ID: 8179296
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vivo imaging for evaluating synaptic integrity in Alzheimer disease].
    Rapoport SI
    Psychol Neuropsychiatr Vieil; 2005 Jun; 3(2):97-106. PubMed ID: 15929923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: new imaging techniques show diagnostic promise.
    Zoler ML
    Geriatrics; 1986 Apr; 41(4):91-2, 94. PubMed ID: 3485065
    [No Abstract]   [Full Text] [Related]  

  • 16. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography.
    Schlageter NL; Carson RE; Rapoport SI
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):1-8. PubMed ID: 3100543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional brain imaging and Alzheimer-type dementia.
    Guze BH; Hoffman JM; Baxter LR; Mazziotta JC; Phelps ME
    Alzheimer Dis Assoc Disord; 1991; 5(4):215-30. PubMed ID: 1781964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study.
    Kumar A; Newberg A; Alavi A; Berlin J; Smith R; Reivich M
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7019-23. PubMed ID: 8346211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
    Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
    Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.